Boehringer-Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim has launched a campaign to educate healthcare providers about biomarker testing to personalize treatment for non-small cell lung cancer patients. Learn more about the "Let's Test" campaign here.